{
    "2020-06-13": [
        [
            {
                "time": "2023-10-10",
                "original_text": "Where Will AbbVie Be in 5 Years?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "future outlook",
                        "long-term growth"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-10",
                "original_text": "VENCLEXTA®/VENCLYXTO® (venetoclax) Plus Azacitidine Demonstrates Statistically Significant Overall Survival Benefit and Improved Remission Rates in Treatment-Naïve Acute Myeloid Leukemia Patients",
                "features": {
                    "keywords": [
                        "VENCLEXTA",
                        "VENCLYXTO",
                        "venetoclax",
                        "Azacitidine",
                        "statistically significant",
                        "overall survival benefit",
                        "remission rates",
                        "acute myeloid leukemia"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}